Literature DB >> 3066087

Pancreatic B-cell function in relation to diabetic retinopathy in Asian Indian NIDDM patients.

C Snehalatha1, R Mohan, V Mohan, A Ramachandran, M Viswanathan.   

Abstract

Pancreatic B-cell function in relation to diabetic retinopathy was studied in 195 NIDDM patients with long-standing diabetes. Background diabetic retinopathy (BDR) was present in 95 (48.7%) and proliferative retinopathy (PDR) in 17 (8.7%) of the subjects. There was no significant difference between the BDR, PDR, and non-retinopathy groups with respect to age, age at diagnosis of diabetes and HbA1 values. Mean duration of diabetes was higher in the PDR group (p less than 0.05). Serum C-peptide values showed no correlation with the presence of retinopathy or with the duration of diabetes. The C-peptide values were widely scattered in patients with BDR and PDR showing no association between pancreatic B-cell reserve and occurrence or severity of retinopathy in NIDDM patients. Thus, decreased pancreatic B-cell reserve does not appear to be a risk factor for diabetic retinopathy in NIDDM patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3066087     DOI: 10.1007/bf02581372

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  18 in total

1.  Diabetic retinopathy. I. The assessment of severity and progress by comparison with a set of standard fundus photographs.

Authors:  N Oakley; D W Hill; G F Joplin; E M Kohner; T R Fraser
Journal:  Diabetologia       Date:  1967-08       Impact factor: 10.122

2.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

3.  Factors influencing beta-cell function and insulin sensitivity in patients with type 2 (non-insulin-dependent) diabetes.

Authors:  L Groop; E M Tolppanen
Journal:  Acta Endocrinol (Copenh)       Date:  1984-08

4.  Determination of free and total insulin and C-peptide in insulin-treated diabetics.

Authors:  H Kuzuya; P M Blix; D L Horwitz; D F Steiner; A H Rubenstein
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

5.  Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.

Authors:  H J Bodansky; S Medbak; P L Drury; A G Cudworth
Journal:  Diabete Metab       Date:  1981-12

6.  The effect of residual beta-cell function on the development of diabetic retinopathy.

Authors:  S Madsbad; E Lauritzen; O K Faber; C Binder
Journal:  Diabet Med       Date:  1986-01       Impact factor: 4.359

7.  Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study.

Authors:  W Burger; G Hövener; R Düsterhus; R Hartmann; B Weber
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

8.  Colorimetric measurement of glycosylated protein in whole blood, red blood cells, plasma and dried blood.

Authors:  J Eross; D Kreutzmann; M Jimenez; R Keen; S Rogers; C Cowell; R Vines; M Silink
Journal:  Ann Clin Biochem       Date:  1984-11       Impact factor: 2.057

9.  C-peptide levels as a criterion in treatment of maturity-onset diabetes.

Authors:  M Rendell
Journal:  J Clin Endocrinol Metab       Date:  1983-12       Impact factor: 5.958

10.  Pancreatic beta-cell function in tropical pancreatic diabetes.

Authors:  V Mohan; C Snehalatha; A Ramachandran; R Jayashree; M Viswanathan
Journal:  Metabolism       Date:  1983-12       Impact factor: 8.694

View more
  3 in total

1.  Relationship between C peptide and chronic complications in type-2 diabetes mellitus.

Authors:  Ramazan Sari; Mustafa Kemal Balci
Journal:  J Natl Med Assoc       Date:  2005-08       Impact factor: 1.798

2.  Association of fasting insulin and C peptide with diabetic retinopathy in Latinos with type 2 diabetes.

Authors:  Jane Z Kuo; Xiuqing Guo; Ronald Klein; Barbara E Klein; Robert N Weinreb; Pauline Genter; Fone-Ching Hsiao; Mark O Goodarzi; Jerome I Rotter; Yii-Der Ida Chen; Eli Ipp
Journal:  BMJ Open Diabetes Res Care       Date:  2014-10-24

3.  Diabetic Retinopathy and Insulin Insufficiency: Beta Cell Replacement as a Strategy to Prevent Blindness.

Authors:  Eli Ipp
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-29       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.